logo
A bullish breakout in this little-known pharma stock is forming, charts show

A bullish breakout in this little-known pharma stock is forming, charts show

CNBC2 days ago

Out of a universe of more than 10,000 tradable names, a strict technical screen we run at CappThesis recently surfaced just six stocks worth a closer look. One of them is Royalty Pharma (RPRX) , and we think the chart deserves our attention right now. There are four key reasons why RPRX stands out: 1. A bullish inverse head-and-shoulders pattern is nearing completion The first — and most importantly from our perspective — is a bullish inverse head-and-shoulders pattern has taken shape over the past several months. These patterns can mark a trend reversal or continuation of a trend. This particular formation has a combination of the two. The pattern has taken shape after a prolonged downtrend from the past few years. That said, the stock has been in rally-mode since bottoming in early December. The formation's neckline is near $34, and the stock is getting closer to challenging that level. A decisive breakout above that line would complete the pattern and trigger a breakout. The projected upside target based on the height of the formation is $39. That level also aligns with resistance from mid-2022. 2. Pattern forming above a larger base breakout What makes this setup even more compelling is that the inverse H & S pattern has been constructed above the breakout zone of a much larger base. The prior breakout occurred near $32, where rally attempts had been snuffed out multiple times since 2023. As the saying goes, once resistance is overtaken, it then becomes support, which is the case now. The ability of RPRX to hold above the prior breakout zone while forming a continuation pattern increases the probability of a sustained move higher. 3. Longer-term context supports the bull case Zooming out, RPRX still has plenty of ground to recover. The stock reached a high of $56.50 shortly after its IPO in mid-2020. Since then, it's been in a multiyear downtrend before bottoming out in late 2024. That prolonged decline may have caused previously eager buyers to become disinterested. This is understandable given how well so many other stocks have done the last two years. However, the sell-off helped reset expectations, valuations, and sentiment—creating a potential springboard if this pattern can be leveraged. Further, the 38.2% Fibonacci retracement of the entire decline from 2020 through 2023 is near $33. That lines up with the 32-breakout zone discussed above, making this area even more important to potentially overtake. 4. Relative strength From a relative strength perspective, RPRX has been outperforming many other biotech counterparts. We can see this via the relative strength line vs. the XBI ETF. Thus, the comeback is evident both on an absolute basis and relative to RPRX's peers, which of course is constructive for further gains as well. The bottom line is that RPRX has done a good job bouncing from its lows, and for that to develop into a more substantial and long-term uptrend, the stock must continue to form and break out from bullish chart formations. It has a chance to continue that process now. DISCLOSURES: None. All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY . THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL'S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR. Click here for the full disclaimer.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AAVE Breaks Key Resistance as DeFi Sector Heats Up
AAVE Breaks Key Resistance as DeFi Sector Heats Up

Yahoo

time2 days ago

  • Yahoo

AAVE Breaks Key Resistance as DeFi Sector Heats Up

AAVE's recent price action demonstrates remarkable strength, climbing another 3.8% over the past 24-hour period and now up 25% since Monday. The token broke through key resistance at $311.50 with exceptional volume, suggesting potential for continued upward movement. This technical breakout was supported by significant fundamental developments in the decentralized finance (DeFi) space. The U.S. Securities and Exchange Commission on Monday held a roundtable discussion about the sector with key figures participating. There, SEC Chair Atkins suggested exploring regulatory exemptions for DeFi firms, spurring optimism for DeFi's future. Market analysts remain optimistic about AAVE's long-term potential, with some setting targets as high as $1,000 per token, though such predictions should be approached with caution. The platform's strong fundamentals and increasing adoption position it as a significant player in the evolving DeFi landscape. Technical Analysis AAVE established a significant high-volume support zone around $302.35-302.52, while breaking through resistance at the $311.50 level during the 12:00 UTC hour with exceptional volume (179,461 units) that exceeded the 24-hour average by over 140%. The overall range of 20.37 points (6.73%) highlights increased volatility, with price action forming an ascending channel pattern and finding momentum after consolidating between $305-310 for several hours. A descending channel pattern formed after the 13:30 selloff that saw volume spike to over 6,100 units at 13:32, with the correction finding support near $312.00, representing a 38.2% Fibonacci retracement of the earlier upward move. Price consolidated between $312.00-312.60 in the final 15 minutes on decreasing volume, suggesting potential stabilization before the next directional move. Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

A bullish breakout in this little-known pharma stock is forming, charts show
A bullish breakout in this little-known pharma stock is forming, charts show

CNBC

time2 days ago

  • CNBC

A bullish breakout in this little-known pharma stock is forming, charts show

Out of a universe of more than 10,000 tradable names, a strict technical screen we run at CappThesis recently surfaced just six stocks worth a closer look. One of them is Royalty Pharma (RPRX) , and we think the chart deserves our attention right now. There are four key reasons why RPRX stands out: 1. A bullish inverse head-and-shoulders pattern is nearing completion The first — and most importantly from our perspective — is a bullish inverse head-and-shoulders pattern has taken shape over the past several months. These patterns can mark a trend reversal or continuation of a trend. This particular formation has a combination of the two. The pattern has taken shape after a prolonged downtrend from the past few years. That said, the stock has been in rally-mode since bottoming in early December. The formation's neckline is near $34, and the stock is getting closer to challenging that level. A decisive breakout above that line would complete the pattern and trigger a breakout. The projected upside target based on the height of the formation is $39. That level also aligns with resistance from mid-2022. 2. Pattern forming above a larger base breakout What makes this setup even more compelling is that the inverse H & S pattern has been constructed above the breakout zone of a much larger base. The prior breakout occurred near $32, where rally attempts had been snuffed out multiple times since 2023. As the saying goes, once resistance is overtaken, it then becomes support, which is the case now. The ability of RPRX to hold above the prior breakout zone while forming a continuation pattern increases the probability of a sustained move higher. 3. Longer-term context supports the bull case Zooming out, RPRX still has plenty of ground to recover. The stock reached a high of $56.50 shortly after its IPO in mid-2020. Since then, it's been in a multiyear downtrend before bottoming out in late 2024. That prolonged decline may have caused previously eager buyers to become disinterested. This is understandable given how well so many other stocks have done the last two years. However, the sell-off helped reset expectations, valuations, and sentiment—creating a potential springboard if this pattern can be leveraged. Further, the 38.2% Fibonacci retracement of the entire decline from 2020 through 2023 is near $33. That lines up with the 32-breakout zone discussed above, making this area even more important to potentially overtake. 4. Relative strength From a relative strength perspective, RPRX has been outperforming many other biotech counterparts. We can see this via the relative strength line vs. the XBI ETF. Thus, the comeback is evident both on an absolute basis and relative to RPRX's peers, which of course is constructive for further gains as well. The bottom line is that RPRX has done a good job bouncing from its lows, and for that to develop into a more substantial and long-term uptrend, the stock must continue to form and break out from bullish chart formations. It has a chance to continue that process now. DISCLOSURES: None. All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY . THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL'S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR. Click here for the full disclaimer.

Is Dogecoin Price Set To Soar? Analyst Predicts Explosive Rally Ahead Amid Correction
Is Dogecoin Price Set To Soar? Analyst Predicts Explosive Rally Ahead Amid Correction

Yahoo

time3 days ago

  • Yahoo

Is Dogecoin Price Set To Soar? Analyst Predicts Explosive Rally Ahead Amid Correction

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Dog-themed cryptocurrency Dogecoin (CRYPTO: DOGE) may be encountering a corrective phase, but analysts were hopeful of significant upside in the ongoing cycle. What Happened: Javon Marks, a widely followed chartist, shared their analysis of Dogecoin's potential trajectory on Sunday. He stated, 'Dogecoin, by its previous cycles, has a high likeliness to make a run to and above $2.28,' Marks projected. Should the prediction come true, it'd mean a whopping 12x upside from the current price. The analyst said these levels act as the 1.618 Fibonacci Level, which DOGE managed to hit and exceed in previous bull cycles, making the chances of it happening again this cycle a bit higher. Trending: New to crypto? on Coinbase. Fibonacci retracement is a technical analysis tool that uses ratios derived from the Fibonacci sequence to determine probable support and resistance levels. These are then used to predict reversals or continuations. The 1.618 level, often referred to as the "golden ratio," is particularly cryptocurrency trader Kamran Asghar noted DOGE's 'strong' structure within an ascending broadening wedge, setting a price target of as much as $3.8. The ascending broadening wedge is a bearish reversal pattern, as part of which price makes higher highs and higher lows before a downward article Is Dogecoin Price Set To Soar? Analyst Predicts Explosive Rally Ahead Amid Correction originally appeared on Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store